House Speaker Cameron Sexton has tucked a $10 million earmark for Vanderbilt’s ALS Research Center into a proposed state budget amendment, setting up a potential windfall for the young center’s funding. The money would help scale patient-focused studies and lab work aimed at earlier detection and new therapies. Lawmakers still have to approve the change before any dollars are released.
Axios Nashville reported that Sexton inserted the $10 million in an amendment to the state operating budget and that the speaker cited personal ties to the cause. “I’ve seen firsthand the incredible work being done at the VARC Lab and the state is proud to continue supporting their mission,” Sexton told Axios Nashville. The amendment is folded into the state’s budget paperwork and will need formal sign‑off from the General Assembly to take effect.
What the Vanderbilt lab is doing
The Vanderbilt ALS Research Center (VARC), led by Dr. Véronique Belzil, blends basic science, biospecimen collection and clinical programs to move discoveries more quickly into patient care, according to Vanderbilt University Medical Center. The center’s work focuses on multi‑omic analyses, human‑derived cell models and integrated clinical research aimed at identifying biomarkers and therapeutic targets. VARC has been recruiting donors and partners to expand its sample repositories and trial capacity.
License plate campaign and fundraising
The center is also trying a more everyday route to raise money: a specialty Tennessee license‑plate campaign that would direct a portion of plate fees to VARC if the project reaches the state’s minimum issuance threshold. The statute authorizing the ALS specialty plate specifies that proceeds be allocated to the Vanderbilt University Medical Center ALS Research Center, in accordance with state law (Tennessee Code). Event listings and the campaign’s preorder page indicate the effort is active and accepting reservations online (Eventbrite).
Why this matters to Tennessee
Supporters say a state-backed infusion could help Nashville attract more ALS trials, biotech partnerships and talent, with potential benefits for both patients and the local economy. The push also follows local advocacy and loss: former state Rep. Gerald McCormick died after an ALS diagnosis in December 2025, according to Tennessee Town & City…